Background
The prevalence of diabetes mellitus is reaching epidemic proportions in many parts of the world. In Germany, diabetes afflicts 7% of the general population¹ and 15.3% of primary care patients². €14.6 billion is spent on diabetes-excess-costs in Germany alone. In addition, diabetes represents an everyday challenge for patients (e.g. blood sugar control and insulin intake). Quality of life can be characterized as the goal of all health interventions and is often used as a short-term outcome measure in clinical trials 4 .
Objectives
To describe the health-related quality of life (QoL) of type 2 diabetics:
-(1) in comparison to nondiabetics -(5) HbA1c adjustment -(2) by age groups -(6) and therapeutic -(3) duration of disease interventions -(4) micro-and macrovascular disease Methods -Data were from the cross-sectional part of the DETECT-study (2003) 5 -Definition of type 2 diabetes based on the doctors' clinical diagnosis -Quality of life assessment resulted from the EQ-5D 6 (German Version of the EuroQol Questionnaire) -Microvascular disease: retinopathy, nephropathy, neuropathy, diabetic foot -Macrovascular disease: coronary artery disease, cerebrovascular disease, peripheral arterial disease -HbA1c values were taken from the patient record
Results
(1) Type 2 diabetics reported more problems in all five EQ-5D domains and had a lower additive total Qol score (68.1) than nondiabetics (72.4) and patients without chronic disease (81.7). Most problems were reported in the domains of pain/discomfort (74.1%), mobility (44.3%), daily activities (34.1%), anxiety/depression (31.4%) and self-care (17.2%). (2-3) Problems in all domains increased with age and duration of disease. . Frequency of problems in the EQ-5D items mobility, self-care, usual activities, pain/discomfort and anxiety/depression as well as the additive total score were analysed in n=6,558 type 2 diabetics. RESULTS: The most frequent QoL restrictions were in the domains of pain/discomfort (74.1%), mobility (44.3%), daily activities (34.1%), anxiety/depression (31.4%) and self-care (17.2%). The mean additive total score was 68.1. That was, after adjustment for age and gender, significantly lower than in nondiabetics (72.4) or in healthy attendees (81.7). Overall and in each QoL domain, problems increased if micro-and macrovascular disease was present, and with the age of patients or duration of diabetes respectively. There were no significant differences between patients with or without therapy (diet, exercise and oral antidiabetics). However, patients with insulin and combined therapy had considerably lower QoL scores, even after adjustment for age, gender, duration of diabetes and presence of micro-and macrovascular disease. HbA1c adjustment had only small effects on the EQ-5D dimensions.
Compared to patients with optimal HbA1c values (< 6%), poorly adjusted patients (HbA1c > 8%) reported significantly more problems at the dimensions mobility and self-care. CONCLUSIONS: Our data provide, in unprecedented detail, the health related QoL of type 2 diabetics in German primary care, highlighting the association of insulin and combined treatments with reduced QoL.
Conclusions
Our data show in unprecedented detail the health-related QoL of type 2 diabetes in German primary care. These data highlight the fact that insulin therapy is associated with reduced QoL scores. Despite the potential benefits of insulin on hyperglycemia and vascular complications, the complex application carries the risk of hypoglycemia and weight gain. These are potential mediators for reduced QOL scores.
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Acknowledgment (4) Compared to type 2 diabetics without vascular comorbidities patients with microvascular as well as with macrovascular comorbidities reported significantly more problems in all EQ-5D domains. Diabetics with both, micro-and macrovascular disease had the lowest score (58.8). (5) HbA1c adjustment had nearly no influence on the patient reported Qol. Insufficient adjusted patients (HbA1c > 8) differed from optimal adjusted diabetics (HbA1c < 6) only in the domains mobility and self care as well as in the total score. (6) There were no significant differences in the EQ-5D scores between patients with oral antidiabetic therapy, patients who received no therapy or only diet and exercise interventions. Compared to diabetics without any therapy, patients with combined therapy (oral antidiabetics + insulin) reported more problems in the self care domain. However, patients with insulin therapy had considerably lower QoL scores (except for anxiety), even after adjustment for age, gender, duration of diabetes, HbA1c adjustment and presence of micro-and macro-vascular disease. 
